Biotech news for Monday, May 11, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
KanawatTH Stock futures inched lower Monday while oil prices rose after Israeli PM Benjamin Netanyahu warned the Iran conflict "isn't over," reigniting fears of intensified Middle East tensions disrupting global energy supplies. Here are some of Monday's bigge…
bluebay2014/iStock via Getty Images The Nasdaq Composite Index ( COMP:IND ) moved higher on Friday in tandem with other major Wall Street indexes following a better-than-expected nonfarm payroll report. The Nasdaq closed 1.71% higher. Major chip and AI-related…
Cn0ra/iStock via Getty Images Capricor Therapeutics ( CAPR ) is down ~11% in Friday trading after announcing following Thursday's market close it is suing Nippon Shinyaku due to a "fundamental pricing flaw" in an agreement the two companies signed in January 2…
wildpixel/iStock via Getty Images Moderna ( MRNA ) is in the early stages of developing a hantavirus vaccine, though its availability could be years away. Shares are up ~14% in Friday afternoon trading. Hantavirus has received renewed interest recently amid an…
mohd izzuan Shares of PTC Therapeutics ( PTCT ) added ~19% on Friday to reach the highest level since January after the rare disease drugmaker raised its full-year outlook, citing a strong uptake for its newly launched phenylketonuria therapy Sephience during…
Earnings Call Insights: BridgeBio Pharma (BBIO) Q1 2026 Management View "We've had $180.6 million of Attruby sales in U.S. Attruby net product revenue this quarter," CEO Neil Kumar said, adding it was "a 24% growth from the last quarter" and "consistent with t…
Earnings Call Insights: Caris Life Sciences (CAI) Q1 2026 Management View “This is a strong start to the year,” said Executive Vice Chairman & Executive VP Brian Brille, highlighting “continued growth, profitability and cash generation” to fund “MCED launc…
Earnings Call Insights: Puma Biotechnology (PBYI) Q1 2026 Management view “Today, Puma reported total revenue for the first quarter of 2026 of $44.8 million,” said Founder, Chairman, President, CEO & Secretary Alan Auerbach, adding that “product revenue ne…
Artiva Biotherapeutics ( ARTV ) added ~8% in the premarket on Friday after the cell therapy developer announced initial data from a company-sponsored mid-stage trial for its lead asset. AlloNK in rheumatoid arthritis, an autoimmune disorder causing joint sympt…
Earnings Call Insights: Absci Corporation (ABSI) Q1 2026 Management View "2026 is going to be a data-rich year for Absci with multiple readouts in front of us," said Founder, CEO, President & Director Sean McClain, adding, "We expect to share preliminary s…
Gilead Sciences ( GILD ) declares $0.82/share quarterly dividend . Forward yield 2.45% Payable June 29; for shareholders of record June 15; ex-div June 15. See GILD Dividend Scorecard, Yield Chart, & Dividend Growth. More on Gilead Sciences Gilead Sciences…
Earnings Call Insights: Organogenesis Holdings (ORGO) Q1 2026 Management View "Net revenue declined 58% year-over-year, driven by a 63% decline in sales of our Advanced Wound Care products" (President, CEO, Chair of the Board Gary Gillheeney), while "Sales of…
Earnings Call Insights: Xenon Pharmaceuticals (XENE) Q1 2026 Management View "We are excited to recap an exceptional quarter for Xenon, where we made tremendous progress toward our goal of becoming a fully integrated neuroscience company" (President, CEO &…